GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease "Diagnostic Odyssey" Seite 1
20.03.2023 - Genome Sequencing and Interpretation Services Progressing Quickly for 1,000 Newborns Enrolled in Study to Date; On Track to Support up to 100,000 Study Participants in Next Four YearsInitial Data and Analysis Presented at the ACMG (American College ... Seite 1
Source: wallstreet-online.de